Peter Lichtlen
Overview
Peter Lichtlen received an average of $906K in total compensation, including $266K in salary, at Sucampo Pharmaceuticals from 2013 to 2015.
Source: SEC filing on April 18, 2016.
Related executives
We found six more executives who work or worked at Sucampo Pharmaceuticals.
Peter Greenleaf
Sucampo Pharmaceuticals
Chief Executive Officer
Peter Kiener
Sucampo Pharmaceuticals
Chief Scientific Officer
Max Donley
Sucampo Pharmaceuticals
EVP, Global Human Resources, Information Technology and Strategy
Matthias Alder
Sucampo Pharmaceuticals
General Counsel
Andrew Smith
Sucampo Pharmaceuticals
Chief Financial Officer
Thomas Knapp
Sucampo Pharmaceuticals